ORMDL3 and hepatocellular carcinoma: In conclusion, the role of the ORMDL3 gene in sorafenib resistance of HCC was thoroughly investigated and described in the current study, showing that inhibition of the ORMDL3 gene increases the sensitivity of HCC cells to sorafenib.